New York, NY – A report by WBZ-TV, the CBS-TV affiliate in Boston, focusing on the most recent Cognizin Citicoline study, is being distributed to all CBS-TV news affiliates nationwide. The news feature includes an interview with Dr. Perry Renshaw, director at McLean Hospital and professor at Harvard Medical School and leading scientific researcher on the health benefits of Citicoline. The Cognizin study demonstrated the patented supplement’s positive impact on the cognitive skills of healthy, middle aged adults.
Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. The maker of the branded ingredients Cognizin® Citicoline, Hydrafend™ Hyaluronic Acid , Lumistor® L-Hydroxyproline, Kyowa CoQ10®, Setria® Glutathione and Sustamine™ Alanyl Glutamine, Kyowa offers manufacturers and formulators one of the industry’s most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.